JMP Securities reaffirmed their market outperform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a report released on Tuesday,Benzinga reports. JMP Securities currently has ...
Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.03 billion market cap biotech company, executed sales of common stock valued at a total of $46,360 over two consecutive days, ...
Investment analysts at HC Wainwright dropped their Q2 2025 earnings estimates for Enanta Pharmaceuticals in a report released on Tuesday, February 11th. HC Wainwright analyst E. Arce now expects that ...
Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...
News Medical on MSN20h
Study explains why tecovirimat fails against some mpox strainsA virus originally found in animals, mpox – which causes the disease of the same name – is now circulating in humans.
The temporary restraining order requires the government to immediately stop any suspensions or pauses that are preventing the ...
Introduction: The study examines accessibility to resources as a key determinant mediating the relationship between female ...
Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...
For too long, women with bleeding disorders have been denied the care that they need, writes columnist Jennifer Lynne.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback